"Instead of putting them through radiation, PETscans and CT scans, which are very expensive and potentially harmful, we are now looking at noninvasive tests that do the same job, " Topol said.
People with a rare genetic form of Alzheimer's, whose specific genetic mutations guarantee that they will develop the disease, tended to show signs of amyloid plaques in PETscans and cerebrospinal fluid 10 to 20 years before the onset of symptoms.